Animal insulin is derived from cows and pigs. Animal insulin was the first type of insulin to be administered to humans to control diabetes. Until the 1980s, animal insulin was the only treatment for insulin dependent diabetes. Currently, the use of animal insulin has been largely replaced by human insulin and human analogue insulin, however, animal insulin is still available on prescription.
This report contains market size and forecasts of Animal Insulin in Global, including the following market information:
Global Animal Insulin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Animal Insulin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Porcine Insulin Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Animal Insulin include Wockhardt UK, Eli Lilly and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Animal Insulin companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Animal Insulin Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Animal Insulin Market Segment Percentages, by Type, 2021 (%)
Porcine Insulin
Bovine Insulin
Global Animal Insulin Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Animal Insulin Market Segment Percentages, by Application, 2021 (%)
Humans
Animals
Global Animal Insulin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Animal Insulin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Animal Insulin revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Animal Insulin revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Wockhardt UK
Eli Lilly
Merck